Cheaper Generic Version of Viagra Will Be Available Soon - Yahoo News UK

Yahoo News UK

Cheaper Generic Version of Viagra Will Be Available Soon Yahoo News UK Viagra is about to get much more affordable. Just in time for its 20th FDA-approval anniversary, the blue little pill—which is one of the most counterfeited drugs in the world—will now have a generic version, offered by Pfizer, the original ... Townsfolk near Viagra plant talk of 'love fumes,' but Pfizer says that's a tall taleKansas City Star all 2 news articles »

from Health - Google News http://ift.tt/2BQKAFE

SLU scientists provide promising approach in designing new drugs for DMD - News-Medical.net

News-Medical.net

SLU scientists provide promising approach in designing new drugs for DMD News-Medical.net In a paper published in the Nature journal Scientific Reports, Saint Louis University (SLU) researchers report that a new drug reduces fibrosis (scarring) and prevents loss of muscle function in an animal model of Duchenne muscular dystrophy (DMD ... Duchenne muscular dystrophy: new drug promises better medicationTheHealthSite all 2 news articles »

from Health - Google News http://ift.tt/2BSrKhA

'Unheard of' responses to bluebird CAR-T therapy seen in myeloma study - Reuters

'Unheard of' responses to bluebird CAR-T therapy seen in myeloma study Reuters (Reuters) - More than half of patients with advanced multiple myeloma who had run out of therapeutic options remained in complete remission after receiving bluebird bio Inc's experimental gene-modifying immunotherapy in a small, early stage study ... and more »

from Health - Google News http://ift.tt/2jja3UO

Cheaper Generic Version of Viagra Will Be Available Soon - Yahoo News UK

Yahoo News UK

Cheaper Generic Version of Viagra Will Be Available Soon Yahoo News UK Viagra is about to get much more affordable. Just in time for its 20th FDA-approval anniversary, the blue little pill—which is one of the most counterfeited drugs in the world—will now have a generic version, offered by Pfizer, the original ... and more »

from Health - Google News http://ift.tt/2B74Y8Y

Gilead's new drug keeps 56 percent of lymphoma trial patients alive - Reuters

Medical Xpress

Gilead's new drug keeps 56 percent of lymphoma trial patients alive Reuters (Reuters) - More than half of trial patients with an advanced, aggressive form of blood cancer lived for at least a year after one-time treatment with Yescarta, a novel therapy sold by Gilead Sciences Inc, according to study results presented on Sunday ... CAR T-Cell Therapies Drive Outcomes in Lymphoma, MyelomaPR Newswire (press release) Phase 2 CAR-T study reports significant remission rates at 15-month follow upEurekAlert (press release) Global CAR T therapy trial shows high rates of durable remission for NHLMedical Xpress Markets Insider -Financial Times all 9 news articles »

from Health - Google News http://ift.tt/2jliYoo